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ABSTRACT
The BCL-2 family of proteins tightly regulates the delicate balance between life and death. The
pore forming Bax is a pro-apoptotic member belonging to this protein family. At the onset of
apoptosis, monomeric cytoplasmic Bax translocates to the outer mitochondrial membrane, forms
oligomeric pores thereby letting mitochondrial cytochrome c enter the cytosol and initiate the
apoptotic cascade. The C-terminal “helix 9” is thought to mediate the membrane binding of
BAX. A 20-amino acid peptide corresponding to Bax C-terminus
(VTIFVAGVLTASLTIWKKMG) and two mutants where the two lysines are replaced with Glu
(charge reversal mutant, EE) or Leu (charge neutralization mutant, LL) have been studied to
elucidate the pore formation capabilities of Bax C-terminus and the underlying molecular
mechanism. Interactions of the wild-type and the two mutant peptides with zwitterionic and
anionic phospholipid membranes caused efficient membrane permeabilization, as documented by
release of vesicle-entrapped fluorescent indicator calcein. Light scattering experiments showed
that vesicles maintained their integrity upon peptide binding, indicating that the content leakage
was due to pore formation and not vesicle degradation. Kinetics of calcein release at various
peptide concentrations were used to determine the peptide-peptide association constants and the
oligomeric state of the pore.
The structure of membrane-bound peptides was analyzed by circular dichroism (CD) and
attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy. CD data
indicated all three peptides reconstituted in lipid vesicles contained α-helical and β-strand
structures. ATR-FTIR experiments indicated that the minimally hydrated samples of peptides in
stacked lipid bilayers (absence of bulk water) were mostly α-helical but adopted mostly β-sheet
iii

conformation in the presence of excess water.
Finally, the depth of membrane insertion of the peptides was analyzed using tryptophan
fluorescence quenching by dibromo-phosphatidylcholines brominated at various positions of
their acyl chains. In case of zwitterionc phospholipid membranes, the single Trp16 was located at
~9 Å from membrane center. In case of membranes containing 30% of an anionic phospholipid,
the depth of membrane insertion of the EE mutant was not affected but the wild-type and the LL
mutant peptides were embedded much deeper into the membrane, with Trp16 located at 3-4 Å
from membrane center.
These results will help achieve a better understanding of the molecular mechanism of membrane
pore formation of Bax protein. In addition, they provide insight into the molecular details of
membrane pore formation by peptides and could facilitate the design and production of cytotoxic
peptides with improved capabilities to lyse cells such as bacteria or cancer cells.
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CHAPTER 1. INTRODUCTION
1.1 Apoptosis

Nature has an on-going balanced phenomenon called Apoptosis, which primarily is the key
player in controlling several important processes in the body including maintenance of tissue
homeostasis and normal development. Apoptosis, also called programmed cell death participates
in homeostasis and removes any defective cells (Mancinelli, Caraglia, Budillon, Abbruzzese, &
Bismuto, 2006) and is a highly regulated process involving several different pathways and
millions of proteins working in perfect coordination.
The mechanism that dictates apoptosis is highly complex. As we mentioned, it consists of a large
number of proteins which in turn participate in several mechanisms for signaling, commitment
and execution of apoptosis via numerous simultaneous pathways (Yu & Zhang, 2004). So when
a cell is committed to die, it attains very distinct phenotypic characteristics, such as blebbing,
destruction of nuclear material by condensation of chromatin. The end result is many small
apoptotic bodies that can be engulfed by macrophages. All this is to ensure that only the cell in
which apoptotic stimulus is generated is affected and all other cells in the vicinity are protected.
In case if there is a malfunctioning in the apoptotic machinery, the result can be disastrous, such
as uncontrolled cell growth found in many diseases. These defective cells survive to collect
further mutations and can even grow under hypoxia and oxidative stress. Conversely, in several
neurodegenerative diseases such as Huntington's, Parkinson‟s or Alzheimer's disease, there has
been shown death of selective neurons which can result in loss of memory and involuntary
1

muscle movements. There are two commonly observed pathways which induce cell death signals
leading to Apoptosis: extrinsic or intrinsic. The extrinsic pathway is initiated by the formation of
death-inducing signaling complex (DISC), and intrinsic pathway where an internal signal
activates Bax, which then translocates to the mitochondria, releasing cytochrome c, propagating
the caspase cascade (Ashkenazi, 2002).

1.2 BCL Associated X-protein

Bax is a member of the BCL-2 family. The BCL-2 family members are known to be pro and
anti-apoptotic proteins which participate in various cell functions. During the apoptotic signal,
Bax inserts itself on the outer mitochondrial membrane, causing membrane destruction and
permeabilization. This results in release of the contents from the inside of the mitochondria into
the cytosol. Several studies have been performed where Bax structure and its sub cellular
location were determined. Cytochrome c associates with Apaf-1 and Procaspase 9 forming
apoptosome, which in turn degrades all internal proteins (Gogvadze, Orrenius, & Zhivotovsky,
2006). All this happens by an antagonistic relationship between the pro and anti-apoptotic
proteins in the Bcl-2 family.
As far as the structural similarities go in various Bcl-2 family members, it has been found that
each member has one or more „Bcl-2 Homology‟ regions. Bax contains 9 α-helices and 3 out of
the four of the BH regions (Reed, 2006). The NMR structure of Bax shows two hydrophobic αhelices hidden from the aqueous phase by seven amphipathic α-helices (Suzuki et. al, 2000). A
hydrophobic cleft can be found that is thought to be where the BH3 domains of the Bax and Bak
2

interact (Veresov & Davidovskii, 2009). The Three dimensional backbone structures of Bax,
BCL-2 and BCL-xL can be superimposed on each other (Suzuki, Youle, & Tjandra, 2000). It is
only the α9 helix that sits in the hydrophobic pocket and participates in the heterodimer
formation with its antagonist. Because of the apparent significance of Bax‟s C-terminal α9-helix,
this project deals with studying its structure and function, i.e., elucidation of pore forming
capabilities and the underlying molecular mechanism.

Figure 1: Process of Apoptosis happening inside the Cell affecting the power house of the cellMitochondria.
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Lipid vesicles were used to model the interaction of Bax C-terminal α-helix with membranes
(Kuwana et al., 2002). Additionally, Bak, another pro-apoptotic BCL-2 family member was
shown to have its secondary structure modified by the composition of lipid membrane. But it is
still unknown whether the 9 helix acts as a protein anchor or is itself a participant in pore
formation.
The focus of this project was on demonstration that the C-terminal α-9 helix of Bax-C, when
isolated from the protein as an individual peptide, can form pores in lipid membranes, and
identification of the biophysical characteristics of the pore, such as the peptide structure, peptidepeptide affinities within the membrane, and the oligomeric state of the pore.
We used circular dichroism (CD), Fourier transform infrared (FTIR) spectroscopy and
fluorescence methods to determine the mode of interaction of Bax-C with membranes and pore
formation. The effect of membrane electrostatics on peptide-membrane interactions was probed
by using zwitterionic membranes composed of 100% 1-palmitoyl-2-oleoyl-sn-glycero-3phosphocholine (POPC), and membranes composed of 70% POPC and 30% of an anionic lipid
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG). To probe the importance of the
double lysine residues near the C-terminus of the -9 helix of Bax, in parallel to the wild-type
peptide two mutants have been studied where the two lysines were replaced with Glu (charge
reversal mutant, EE) or Leu (charge neutralization mutant, LL).

4

Figure 2: The NMR structure of BAX (Suzuki et al., 2000). Helices are colored red, and the Cterminal helix 9 is highlighted in green.

1.3 Bax Oligomerization and Localization

Based on previous studies, we have tested the working hypothesis that key mitochondrial
targeting elements reside in Bax‟s C-terminus. We have examined a putative membrane- binding
stretch of Bax, i.e., the C-terminal helix that contains double lysines at positions 189 and 190
(Petros, Olejniczak, & Fesik, 2004; Reed, 2006). The same biophysical techniques like FTIR and
CD were used to define the parameters of membrane insertion using synthetic membranes in the
form of large unilamellar vesicles (LUVs).
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Figure 3: C-terminal helix 9 of Bax is shown with residues Trp 16 and Lys 17, 18 highlighted in
yellow and blue, respectively (Suzuki et al., 2000).

1.4 Objective of the project

The main objective of this project was to test the hypothesis that the α-9 helix of Bax has
membrane binding and pore forming capability and identify the molecular and structural basis of
pore formation. Vesicle content leakage and biophysical studies have been carried out using
synthetic peptide with the sequence (VTIFVAGVLTASLTIWKKMG), which corresponds to the
last 20 amino acids of Bax to accomplish this objective. The contribution of the two lysine
residues to the structure and membrane permeabilization activity of the peptide was studied by
using two mutants of the synthetic 20-mer peptide where the lysines were replaced with either
glutamic acid or leucine residues. The effect of membrane charge was evaluated by using
6

zwitterionic POPC membranes as well as membranes containing 70% POPC and 30% of an
anionic lipid POPG. These studies were aimed at achieving a molecular model of the membrane
pores made by the Bax C-terminal peptide, which would have a two-fold impact. First,
identification of the mode of membrane binding and membrane permeabilization by the peptide
would provide molecular insight into the mechanism of action of Bax on mitochondrial
membranes. Second, analysis of the structure and pore forming activities of the wild-type and
mutant peptides would open new possibilities for design and production of potential cytotoxic
peptides that could kill bacteria, fungi, or cancer cells by perforation of their plasma membranes.

7

CHAPTER 2. LITERATURE REVIEW
2.1 Are there Bax receptors in OMM?

With the induction of apoptotic stimuli, Bax translocates to the Outer Mitochondrial Membrane
(OMM) from the cytosolic environment with the aim of permeabilizing OMM. Due to this, all
other cellular structures maintain their integrity at the beginning of apoptosis and only Bax
functions at this time. If this is not true, then the cell would become necrotic leading to complete
disassociation of the entire cellular environment. Hence, the reason for Bax to go first and bind
specifically to the OMM is because of the type of lipids along with membrane bound proteins
which can be classified as either membrane bound proteins with a single or multiple α-helical
transmembrane domains or proteins with predominant β-structure (Ott, Norberg, Zhivotovsky, &
Orrenius, 2009). Bax falls in the first category and carries a positive charge with an isoelectric
point of 10.5, facing the intermembrane space, which is a characteristic of several other single
membrane spanning proteins (Martínez-Senac, Corbalán-García, & Gómez-Fernández, 2002).
OMM has a distinct lipid composition, in that cardiolipin is present in mitochondrial membranes
at significant quantities. Cardiolipin binds cytochrome c, which is found in the mitochindrial
matrix. This interaction controls the degree of cytochrome c demonstrating that apoptosis is a
highly regulated phenomenon. It has also been shown that cardiolipin is a receptor for
Procaspase 8, another apoptotic regulator (Garcia-Saez, Fuertes, Suckale, & Salgado, 2010;
Gogvadze et al., 2006; Lovell et al., 2008). Strong evidences have been provided for
mitochondrial targeting of tBid and Bax to the outer membrane of other cellular organelles.
8

However there is a very little cardiolipin (roughly 0.3-1.4%) found in the OMM but often
researchers are using 10-40% of cardiolipin which strongly exceeds the amount in OMM to
answer the questions about the presence of receptors. An integral protein of OMM- VDAC,
forms complexes BCL-2 family proteins Bax, Bak, and tBid and is considered as a “receptor” for
these proteins (Zeth et al, 2010). However, no strong evidence has yet been provided for the
existence of specific Bax receptors.

2.2 Knowledge about Bax structure and function

2.2.1 Current knowledge about Bax

Even though several studies have shown that mitochondrial translocation of Bax causes the up
regulation of Ca2+stores with its association with pro-apoptotic proteins, the accurate mechanism
of Bax is still unknown (Zong et al., 2003). Out of the several studies performed on Bax over the
years, one suggests that Bax permeabilization of the OMM is due to the similarity in structure
between the multi domains of BCL-2 family with diphtheria toxin, which forms proteintranslocating pores in the endosomal membrane (Yip & Reed, 2008). Another study suggests that
upon Bax binding, fragmentation of mitochondria takes place (Karbowski & Youle, 2003). Even
with these studies, the molecular determinants of binding of Bax to the mitochondrial membrane,
the pore structure and its oligomeric state remain elusive. Protein-protein interactions have been
experimentally studied to elucidate the translocation mechanism and its mode of action. A very
commonly used assay system, called Yeast two-hybrid system was established (Willis et al.,
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2005). It is thought that Bax self associates through BH1 and BH2 domains. If there is any
anomaly in the heterodimers, then the cell becomes more susceptible to apoptosis.
Apart from BLC-2 family of proteins, several other signaling pathway proteins also contibute to
the regulation of Bax. Important among those is a serine threonine kinase called AKT which
inhibits structural change within Bax, which may inhibit mitochindrial binding, preventing
apoptosis (Brunet et al., 1999). Since no regulatory changes have been observed in the Bax
phosphorylation, the mechanism of AKT inhibition is still not clear. In human keratinocytes, on
the other hand, UVB activation of p38 MAP Kinase promotes the movement of Bax to
mitochondria. Several upstream effector proteins also modulate the activity of Bax but even with
these theories, the actual mechanism for the membrane translocation is still unclear (Reed, 2006;
Torrecillas et al., 2005).

2.2.2 Gap in knowledge about Bax

While previous research in the BAX field has given enormous information about the regulation
and mechanism of BAX, the key players in its activation have not been identified. Even the
recent structural studies are somewhat contradictory and do not reveal the mechanism of Bax
activation. One study suggests that the C-terminal domain is the major component in the protein
responsible for membrane insertion while the other study proposed that the amino terminal acts a
mitochondrial targeting sequence (Karbowski & Youle, 2003; Zong et al., 2003).Yet another
study comes across as a contradictory to the two previous studies and suggests that the pivotal
role of the N-terminal domain is the commitment to apoptosis (Gogvadze et al, 2006). The role
of Bax α-9 helix segment has also been suggested as a transmembrane domain that could
10

translocate BAX to the OMM (Ausili et al. 2008). So due to these ambiguous results, there is a
strong need to gather well defined structural data which focuses on the mechanism of activation
and function of Bax with respect to the lipid membrane binding. In order to fill this gap, more
work needs to be performed to determine the critical membrane binding domains in the BAX
structure and also its intermolecular and intra molecular interactions (Tschammer, 2007).

2.3 Analysis of Protein−Lipid Systems by ATR-FTIR Spectroscopy

In an attenuated total reflection- Fourier transformed infrared (ATR-FTIR) experiments, an
internal reflection plate made of high quality Germanium is used to deposit the peptide on its
surface (Tatulian et al., 1995). A thin layer of lipid containing the reconstituted peptide is
deposited and an infrared beam is directed onto the plate. The beam undergoes several internal
reflections from one end of the plate to another, leading to an exponentially decaying evanescent
field at both surfaces of the Ge plate. Because energy is transferred from the evanescent field to
the deposited layer of lipid and peptide, a distinct absorption spectrum will be generated which
carries a plethora of structural information for both the lipid and protein (of peptide) molecules.
FTIR spectroscopy is very sensitive to protein conformational changes and is not limited to the
molecular size of the sample (Jackson & Mantsch, 1995). Another advantage of using ATRFTIR for peptide structure determination is due to absence of light scattering problems unlike
circular dichroism or fluorescence experiments in the UV region. ATR-FTIR is unique in that
the spectrum of any protein-lipid combination does not require any labeling and generates well-
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resolved absorbance bands for both lipids and proteins and also for various structural groups of
these protein molecules (Goormaghtigh et al., 1990; Tatulian et al., 1995).
Secondary structure of proteins can be elucidated by amide I absorption frequencies which is
generated by the contributions from the C=O (80%) and C-N vibrational stretching found
between 1600 to 1700 cm-1. The particular characteristics of the structural components that make
up the amide I mode can be used to calculate the proportion of a protein‟s secondary structure
(different secondary structures generate amide I vibration at distinct frequencies) (Tamm &
Tatulian, 1993). N-H bending (60%) and C-N stretching (40%) contribute to the amide II band,
and is found between 1520 to 1580 cm-1. It is perhaps the most useful spectral range in
measuring the amide H/D exchange and the protein‟s “dynamic structure”.
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Table 1: Amide I Frequencies of Most Typical Secondary Structural Elements in Proteins in H2O
and D2O Environments (Tatulian, 2003).

frequency(cm-1)

Secondary structure

H2 O

D2O

αI-helix

1658−1650

1655−1646

αII-helix

1666−1658

1658−1652

310-helix

1670−1660

1670−1660

↑↓β-sheet

1638−1632

1636−1630

↑↓β-sheet

1695−1675

1680−1670

Intermolecular β-sheet

1625−1615

1625−1615

β-turns

1685−1655

1675−1640

γ-turns

1690−1650

1690−1650

irregular

1660−1652

1648−1640

Amide or aromatic side
chains

1618−1605

1615−1600

2.4 Lipid Monolayers and Bilayers

Several models have been established to study the cellular membranes which will mimic the
natural environment inside the cell (Liu & Regen, 1993). For this purpose, lipid vesicles have
been used as model membranes which will allow the study of protein interaction with the
13

mitochondrial membrane (Frey & Tamm, 1991). One very commonly used method for
deposition of lipid on the solid surface would be direct spreading but this method has the
limitation since not all the protein can be uniformly distributed across the area of the Ge plate.
Other than that the dry protein-lipid solution is believed to be far from the physiological state of
the actual cellular environment (Fa et al., 2006). Real physiological condition can be modeled to
a greater amount in comparison to the systems where dried lipid samples are deposited.

Figure 4: Creating of Large Unilameller Vesicles using extruder (left) and POPC LUV is created
by passing through 100 nm pore size membrane 15-20 times (right). (Courtesy Avanti Polar
Lipids, Alabaster, AL)

Langmuir-Blodgett (LB) technique is used to deposit the lipid monolayer on the Ge plate. In
order to create a lipid bilayer, lipid vesicles containing peptide are injected into the ATR cells so
that the peptide-lipid vesicle suspension gets deposited on top of the already coated monolayer.
The vesicles have been prepared by sonication and are 30-50 nm in diameter. Once the bilayer is
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created, secondary structure can be determined using spectral measurements obtained at two
different polarizations of the incident light (Jackson, Haris, & Chapman, 1989).

2.5 Circular Dichroism (CD)

We used Circular Dichroism (CD), a well known method for protein secondary structure
determination (Brenner et. al, 2000) as a complementary method to FTIR. The asymmetry of the
-carbon backbones of proteins result in chirality leading to optical activity. This optical activity
can be useful for the study of α helices or -sheets which constitute large fractions of most
proteins. Secondary structure determination from CD is done using a number of modeling
techniques.
CD spectra are composed of the difference in the absorption of plane polarized light, which has
been resolved into its left and right handed components. The following equation is used:
Δɛ = ɛL - ɛR
Where ɛ is the molar extinction coefficient for either the left (L) or right (R) vectors,
respectively. The emerging beam is elliptically polarized (Fu et al., 1998). CD spectrum for each
type of secondary structure is different and hence is a characteristic feature of each secondary
structure. The spectrum for an α helix has two minima at 208 nm and 222 nm, β- sheets only give
one minima at 215 nm. The spectrum of unordered structures has a weak maximum around 220
nm along with a deep minimum at 200 nm.
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Figure 5: Typical CD spectra corresponding to different structures.
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CHAPTER 3. MATERIALS AND METHODS

3.1 Materials

1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC), dodecylphosphocholine (DPC), 1palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) and brominated lipids were purchased from
Avanti Polar Lipids, Inc. Alabaster, AL. Bax peptides (Ac-VTIFVAGVLTASLTIWKKMGNH2) along with two other mutants were from Biopeptide San Diego, CA. Sephadex® G-50
medium was from Amersham Biosciences (Uppsala, Sweden) and SM-2 Biobeads from BioRad Laboratories (Hercules, CA). Analytical and highest purity chemicals from Sigma
Aldrich Co. (St. Louis, MO). Calcein disodium salt from Fluka Analytical, Sigma Aldrich
(St. Louis, MO) while polycarbonate filters for LUV preparation were purchased from
Avastin, Inc. (Ottawa, Ontario, Canada).

3.2 Calcein Release Assay

Large Unilamellar Vesicles (LUVs), a model membrane system, were generated from a 10
mM suspension of a lipid mixture as described above. Dried lipid film was suspended in 10
mM calcein disodium salt in buffer and the mixture was then extruded through a pair of 200
nm polycarbonate filters 15 times (Rabzelj et al., 2008). Free calcein was removed from the
calcein entrapped vesicles using SephadexTM G-50 column. The buffer flow rate was
maintained at 3 mL/min using Econo Pump (BioRad, Hercules CA) and calcein-loaded
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vesicle fraction was collected. 150 µM solutions of all three peptide samples (Bax-KK, BaxLL and Bax-EE) are prepared (Kaushik, Krishnan, Prausnitz, & Ludovice, 2001) in 6 mM
DPC using 20 mM phosphate buffer, pH 7.2, containing 0.8 mM EGTA and 150 mM NaCl.
The peptide/DPC sample was then diluted 10 times by adding to the calcein loaded vesicles
to make it below its CMC (Fu & Singh, 1999). The increase in fluorescence due to calcein
release from LUVs was measured between 500-550 nm (λmax =513 nm) with an excitation
wavelength of 490 nm on Jasco 810 spectropolarimeter at 37oC every 20 s for 30 min
(Bensikaddour et al., 2008; Fu, Lomneth, Cai, & Singh, 1998). Only calcein that leaked from
vesicles emitted measurable fluorescence because calcein at high concentration within
vesicles (i.e., 10 mM) self quenches (Fu and Singh, 1999). The minimum and maximum
(100% leakage) fluorescence intensity corresponding to addition of pure DPC (0.6 mM) and
0.05% Triton X-100 to the vesicle sample was determined respectively (Lovell et al., 2008;
Martínez-Senac et al., 2002).

3.3 Circular Dichroism and Fluorescence measurements

CD and fluorescence spectra of membrane-reconstituted peptides were measured using a J-810
spectrofluoropolarimeter (Jasco Corp., Tokyo, Japan), as described (Qin et al., 2004; Pande et al.
2006). In both cases, a 0.4 cm path-length rectangular quartz cuvette containing a magnetic stir
bar and mounted in the temperature-controlled sample holder was used. For CD measurements,
LUVs were prepared using pure POPC or a 7:3 combination of POPC/POPG, without Br2PC.
Tryptophan fluorescence of the peptides was monitored using excitation at 290 nm. The
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excitation and emission slits were 4 nm and 10 nm, respectively. For CD and fluorescence
measurements, 10 and 5 scans were co-added to obtain the average spectra. Measurements were
conducted either at 20oC or 37oC as indicated.

3.4 ATR-FTIR Spectroscopy

3.4.1 Sample Preparation

Lipid-peptide samples for ATR-FTIR experiments were prepared using previously described
methods (Goormaghtigh, 1999; Vigano et al., 2003) with slight modifications. Two µL of the
peptide dissolved in DMSO at 12.5 mM was dried with compressed nitrogen and by desiccation.
The dry sample was dissolved in ~20 L of hexafluropropanol, and 125 µL of 10 mM lipid
dissolved in CHCl3 was added. The peptide-lipid solution at lipid-to-peptide molar ratio of 50:1
was carefully spread onto one surface of a ~7 cm2 clean germanium plate with 45o aperture
angles and dimensions of 5×20.1 cm3 (Spectral Systems, Irvington, NY). The sample was dried
in a desiccator; the germanium plate was assembled in a home-made ATR sample holder, which
was mounted into the FTIR spectrometer at a position corresponding to a 45o incidence angle.
This setting corresponds to approximately 20 internal reflections at one side of the plate. The
thickness of the sample was evaluated to be ~1.6 µm, which is significantly thicker compared
than the decay length of the evanescent field (~0.3 m). After measurements of the dry sample at
two polarizations, the germanium plate with the sample was subjected to D2O vapors for 1 hr in a
confined volume, and the spectra of the D2O-humidified sample were collected. This was
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followed by injection of a D2O-based buffer (150 mM NaCl, 10mM Hepes, pD 6.8) into the
ATR cell and additional spectra collected.

3.4.2 IR Spectroscopy

The signal/noise ratio of FTIR spectra was improved with 200 scans on a Bruker Vector 22
Spectrophotometer, which was purged continuously with dried air (del Mar Martínez-Senac,
Corbalán-García, & Gómez-Fernández, 2001). The reference spectra were measured using a bare
germanium plate or a sample prepared using plane lipid without any peptide. Atmospheric water
humidity spectra were measured at both polarizations by collecting spectra at various times,
using the bare germanium plate, and were used for clearing the sample spectra from noise
generated by residual humidity, when necessary.

Figure 6: Internal Reflection of the infrared light within Ge plate creating an evanescent field at
the surface where lipid-peptide are bound (Tatulian, 2003).
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3.5 Membrane Insertion

LUV preparation: 100% POPC and 70% POPC and 30% POPG at 10 mM final concentration in
chloroform. For each of the samples, 10 mol % of 6,7- 9,10- and 11,12- brominated lipids are
also added to make the total lipid concentration of 1.2 mM (Bensikaddour et al., 2008).
Chloroform was removed by evaporation with compressed nitrogen followed by vacuum
desiccation for 1 hr. The lipid film was suspended in 0.5 mL of 20 mM phosphate buffer in H2O,
pH 7.2, containing 0.8 mM EGTA. LUVs are extruded by passing the lipid solution through the
extruder with two 100 nm pore size filters and performing the extrusion 15 times to achieve the
uniform vesicles (Ray, Scott, & Tatulian, 2007). 0.3 mM of peptide sample (Bax-KK, Bax-LL
and Bax-EE) is taken from the stock in DMSO, solvent is removed under the stream of N2 and
vacuum desiccated again for 2 hrs. 9 mM DPC is added along with hexafluoroisopropanol
(HFIP) to dissolve the peptides. The solvent again is removed by a stream of N2 and suspended
in 32 µL of 20 mM phosphate buffer (Rodionova et al., 1995). DPC is removed by vortexing the
sample with SM-2 Biobeads (10% by weight) for 2 hrs.10 fold dilution of peptide/DPC sample is
done in the vesicles so that it goes well below CMC (~1.5mM). Both CD and fluorescence with
290 nm excitation of Trp are measure at 20oC and 37oC.
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CHAPTER 4. RESULTS

4.1 Calcein Release Assay

Studies on peptide-mediated calcein release from phospholipid vesicles are being conducted
to see if the wild type and/or the mutant peptides are able to cause membrane destabilization
and content release. Colum chromatography is performed using Sephadex® G-50 column, a
constant flow rate of 3ml/min is maintained and 10 drops per tube are collected.
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Figure 7: Fraction collection for 1 mM calcein-loaded-POPC vesicles using G-50 column at
25oC using 20 mM phosphate buffer containing 0.8 mM EGTA and 150 mM NaCl, pH 7.2
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4.1.1 Calcein Release Assay with 100% POPC vesicles

Figure 8: Bax mediated calcein release from POPC vesicles demonstrating differences in
fluorescence intensity. Emission is measured between 500- 560 nm. Maximum intensity is seen
at 513 nm. 0.05% Triton X-100 is used as positive control.

Figure 9: Fluorescence kinetics of entrapped 10 mM calcein release from vesicles prepared from
1 mM of POPC in 20 mM Phosphate buffer, pH 7.2. (Blue-Bax KK, Green: Bax-EE, Black: Bax
LL, Red- Triton, Purple-DPC)
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4.1.2 Calcein Release Assay with 70% POPC and 30% POPG

Figure 10: Bax mediated calcein release from 70% POPC + 30% POPG vesicles demonstrating
differences in fluorescence intensity. Emission is measured between 500-560 nm. Maximum
intensity is seen at 513 nm. 0.05% Triton X-100 is used as positive control.

Figure 11: Fluorescence kinetics of entrapped 10 mM calcein release from vesicles prepared
from 1 mM of POPC in 20 mM Phosphate buffer, pH 7.2. (Blue-Bax KK, Green: Bax-EE,
Black: Bax LL, Red- Triton, Purple-DPC)
24

4.2 Membrane permeabilization by peptides

Calcein fluorescence is self-quenched at concentrations higher than ~1 mM (Rapaport et al.,
1996; Park et al. 2006; Klocek et al. 2009). The concentration-dependence of calcein
fluorescence is shown in Fig. 12A. If lipid vesicles are loaded with calcein at relatively high
concentrations, then membrane permeabilization can be detected by calcein release into the large
external compartment, resulting in calcein dilution, dequenching, and increase in fluorescence
intensity. We used lipid vesicles 200 nm in diameter at 0.5 mM total lipid concentration loaded
with 10 mM calcein. Using 4.0 nm for POPC or POPC/POPG membrane thickness (Vogel et al.,
2000) and 0.68 nm2 for cross-sectional area per lipid (Seelig et al., 1993), one can evaluate a 0.31
% fraction of vesicle-entrapped volume. Upon total disruption of the vesicles, calcein
concentration in the external volume will increase from zero to ~0.03 mM, which corresponds to
increase in fluorescence intensity to 1.0-1.1 relative units, as judged from data of Fig. 12A.
Fig. 12B indicates a rapid increase in calcein fluorescence intensity upon addition of 1.667 µM
of the wild-type peptide BaxC-KK. To ensure that calcein release from the vesicles was due to
membrane pore formation rather than membrane disruption, vesicle integrity was estimated by
right angle static light scattering on a J-810 spectrofluoropolarimeter. When incident light was
used at 550 nm, slightly red-shifted light scattering from vesicles was detected (Fig. 12C).
Addition of 1/10th volume of buffer resulted in a ~10% decrease in intensity of scattered light
due to dilution of the vesicle suspension. Addition of 1/10th volume of plain DPC (at final DPC
concentration of 0.6 mM) or any of the three peptides solubilized in DPC at final peptide
concentration of 1.667 µM to15 µM did not result in any additional decrease in light scattering,
indicating that neither the peptides nor DPC caused vesicle disruption. Triton X-100 caused
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strong reduction of light scattering. The residual scattering was due to mixed Triton X-100-lipid
micelles, indicating complete degradation of the vesicles by Triton X-100.

Figure 12: Calcein release experiments spectra showing (A) Calcein concentration curve, (B)
increase in Fluorescence upon addition of Bax-KK and (C) Light scattering data pre (closed
circles), post the addition of buffer (open triangles), the peptides, or Triton X-100 (rhombs).
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4.3 Analysis of Pore formation kinetics

Following a previously described formalism for peptide-mediate membrane pore formation, we
propose that introduction of peptide into LUVs results in rapid insertion of the peptide followed
by membrane destabilization and a slower process of formation of the final structure of the pore.
In case of the wild type peptide, the fast and slow components are characterized with time
constants of 10-30 s and 20-10 min, respectively, which are likely related to these processes.
Upon membrane binding of the peptides and pore formation, the observed calcein fluorescence
increases from zero to equilibrium value Feq. If eventually every peptide contributes to pore
formation, then the concentration of free peptide at time t, [P]t, can be expressed through the
total peptide concentration, [P]0, and fluorescence intensity at time t, Ft, as follows:


 P t   P 0  1 


Ft
Feq






(1)

Given the hydrophobic nature of the peptides and their poor water solubility, it is reasonable to
assume that nearly all of the peptide is membrane bound. We use a model of pore formation
where peptide molecules associate with each other in a stepwise fashion to form an oligomeric
assembly. If the pore is composed of n  2 peptide molecules, then addition of each molecule can
be considered a second-order process that is described as follows:

1
1

k t
 Pt  P0 a

(2)
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where ka is the second-order association rate constant in units M-1s-1. Combination of Eqs. (1)
and (2) yields:

Feq

 P0  Feq  Ft 



1
k t
 P0 a

(3)

Equation (3) indicates that the second-order rate constant of pore formation, ka, can be
determined as the slope of the time dependence of the term at left-hand side of Eq. (3). Values of
Feq are tabulated in Table 2.

Generally, a bimolecular process where reactants A and B combine in a complex AB, which then
either dissociates to A and B or leads to the formation of the final product P, can be describe as
shown in Scheme 1:

kp

A  B  ka AB  P
kd

Scheme 1
Here, ka and kd are the forward and reverse rate constants of complex formation, and kp is the rate
constant of product formation. The effective (observed) rate constant of product formation is

keff 

ka k p

(4)

k p  kd
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Two cases can be considered. First, product formation is much faster than complex dissociation
(kp >> kd). This leads to:

keff  ka

(5)

Second, complex dissociation is much faster than product formation (kp << kd). This leads to:

keff 

ka k p
kd

 Kk p

(6)

Here, K is the peptide-peptide association constant in units M-1.
The oligomeric state of the pore, i.e. the number of peptide monomers per pore, can be estimated
using a formalism of reversible aggregation (Nir, Nieva. 2000, Nieva, 2003). This model is
applicable to general cases when the sample contains j = 1 to S different types of vesicles, such
as vesicles of different size categories, and each vesicle of type j contains up to Nj peptide
molecules. If the number of peptides per pore is n, then only vesicles containing peptides i = n to
Nj (n  i  Nj) will leak. The fraction of leakage reached at t   (Feq, see above) relative to the
maximum possible leakage (Fmax , caused by vesicle disruption by Triton X-100), is given as:

N

S
j
Feq
n

1


Frel 
 q
 n  nq  q  Σ Σ Ai, j f j
Fmax 
i  n j 1

where
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(7)

1

q

(7a)

   1
2

  1

1
4K  P 
0

(7b)

In Eq. (7), Ai,j is the normalized fraction of vesicles of size j that contain i bound peptides, and fj
is the fraction of encapsulated volume of vesicles of type j normalized relative to the total
encapsulated volume. Considering that the vesicles used in this work have been extruded through
membranes of defined pore size (200 nm), only one type of vesicles can be considered, i.e., S =
1. Furthermore, it is reasonable to assume that all vesicles contain similar numbers of peptides,
i.e. the average number of peptide molecules per vesicle. Under our experimental conditions
(total lipid concentration of 0.5 mM and peptide concentrations of 1.667 M, 5.0 M, and 15.0
M), this number varied between 1180 and 10650, which is much larger than any conceivable
number of peptide molecules per pore. With these considerations, we arrive at

S



j 1

fj 1

Nj

and

 Ai, j  1

(8)

i n

Combination of Eqs. (7) and (8) yields:

Frel  qn1  n  nq  q 

(9)

If experiments of vesicle content release are performed at various peptide concentrations, then
the experimental values of Frel can be determined at each concentration and compared with those
calculated through Eq. (9) using different values for n. Values of n at which the calculated and
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measured values of Frel merge can be used as the number of peptide molecules per pore. It
should be noted that this procedure of determination of n is more accurate than the model
considering an irreversible aggregation, in which overestimated values of n are obtained (Parente
et al, 1990). Furthermore, the calculated value of Frel does not depend on the fraction of
membrane-bound peptide. If the fraction of membrane-bound peptide decreases x times, the
slope of the linear relationship given by Eq. (3), and hence ka, and consequently K (Eq. 6)
increase x times. Thus, in Eq. (7b) a certain change in membrane-bound peptide concentration
[P]0 is compensated by an opposite change in K, resulting in no change in values of q (Eq. 7a)
and Frel at a given n. This indicates that using the experimental values of the total peptide
concentration for [P]0 does not introduce error in evaluated parameters of pore formation.
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Table 2: Kinetic parameters of calcein release from vesicles composed of 100% POPC (PC) or
70% POPC + 30% POPG (PC/PG) derived from fitting the data with a double-exponential
equation: Ft = Feq – a1exp(-k1t) – a2exp(-k2t), where Ft is calcein fluorescence intensity at time t,
Feq is the fluroscence at t→∞, k1 and k2 are the rate constants. Cp is the total peptide
concentration in µM.

Cp

Feq
PC

PC/PG

a1
PC

PC/PG

k1 (s-1)

a2
PC

PC/PG

PC

PC/PG

k2 (s-1)
PC

PC/PG

BaxC-KK
1.667 0.5622 0.5969

0.2974 0.1917

0.2633

0.3724

0.002939

0.001936 0.086286 0.038464

5.0

0.6224 0.6312

0.1722 0.2236

0.4508

0.3949

0.002589

0.002632 0.105304 0.050731

15.0

0.6920 0.6726

0.1555 0.1618

0.5283

0.5078

0.0035407 0.005551 0.074997 0.115064

BaxC-EE
1.667 0.3811 0.2555

0.1652 0.1175

0.2008

0.1387

0.001164

0.000817 0.000401 0.002029

5.0

0.5912 0.6078

0.4165 0.4592

0.1784

0.1529

0.001362

0.001256 0.015592 0.008628

15.0

0.7075 0.7020

0.2238 0.2382

0.4733

0.4596

0.003443

0.003539 0.025874 0.015385

BaxC-LL
1.667 0.2076 0.3264

0.1244 0.2412

0.07143 0.0784

0.000629

0.001130 0.004593 0.007391

5.0

0.2781 0.5085

0.2002 0.3918

0.07003 0.1085

0.001035

0.000573 0.017925 0.011937

15.0

0.3969 0.6134

0.1933 0.2302

0.2013

0.001136

0.001239 0.010174 0.000376
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0.3390

Now once the double exponential constants are calculated, there is need to evaluate the degree of
affinity between those peptide molecules. For this purpose the affinity constants are calculate.
The rate constants ka1 and ka2 shown in Table 3 are 103-104-fold smaller than the estimated value
of kdiff, indicating that the pore formation is much slower than a simple diffusion-controlled
process. This in turn implies that in most cases peptides can diffuse away from each other before
the complex is formed. Thus, the rate constant of peptide complex formation, kp, is the ratedetermining step, and therefore, according to Eq. 6, keff = Kkp. Here, keff is the observed secondorder rate constant, i.e. those summarized in Table 3 as ka1 and ka2, K is the peptide-peptide
binding constant, and kp is the rate constant of peptide complex formation. Analysis of the
kinetic data on peptide-induced vesicle content leakage indicates rapid membrane binding of the
peptide, with time constants in the range of seconds, followed by two distinct processes that can
be described using bimolecular rate constants of 5000-9000 M-1s-1 at 5-10 min following peptide
addition and 20000-40000 M-1s-1 at later times (Table 3). The process taking place at earlier
times likely reflects the nucleation of the pore complex, which is the rate-limiting step of pore
formation, and is characterized with peptide-peptide affinity constants of K1 = (1.3-3.7)106 M1

. The second process is interpreted in terms of formation of the final pore structure, which

proceeds at a 4-fold higher speed and results in peptide-peptide association with affinity
constants of K2 = (0.5-1.4)107 M-1 (Table 3). These results for the mutant peptides fit well with
the model for initial nucleation of the pore structure, including 2-3 peptide molecules, and further
progression of the process to the final pore structure that can probably contain a varying number
of peptide molecules which appears to be limited by of n = 8 molecules per pore (see below for
more detail on the mechanism of pore formation).
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Table 3: The fraction of maximum possible vesicle content leakage (Frel), second-order rate
constants (ka1 and ka2), and peptide-peptide affinity constants (K1 and K2) characterizing
membrane pore formation by the peptides. Parameters ka1 and K1 were derived from the data for
initial time period (5-10 min) following addition of peptides to the vesicles, while ka2 and K2
were derived from data corresponding to later times (~ between 10-20 min). Cp is the total
peptide concentration in M.

Cp

Frel
PC

PC/PG

ka1 (M-1s-1)

ka2 (M-1s-1)

PC

PC

PC/PG

PC/PG

K1 (M-1)

K2 (M-1)

PC

PC/PG

PC

PC/PG

BaxC-KK
1.667 0.755

0.843

8966

7190

41800

21407

3.05106

3.71106

1.42107

1.11107

5.0

0.836

0.892

4459

4608

34090

19538

1.72106

1.75106

1.31107

7.42106

15.0

0.929

0.950

4871

7318

21973

26868

1.37106

7.71105

6.21106

4.84106

BaxC-EE
1.667 0.513

0.332

552

1276

1092

2267

4.74105

1.56106

9.38105

2.77106

5.0

0.796

0.789

710

594

1672

1010

5.21105

4.73105

1.23106

8.04105

15.0

0.952

0.912

1852

2389

6892

8156

5.38105

6.75105

2.00106

2.30106

BaxC-LL
1.667 0.317

0.407

1208

1526

---

2748

1.92106

1.35106

---

5.0

0.425

0.634

598

243

---

---

5.77105

4.24105

---

---

15.0

0.606

0.765

373

70

---

---

3.28105

1.87105

---

---
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2.43106

4.4 The Structure of Membrane-Bound Peptides by ATR-FTIR

The peptide sample was mixed with two different lipids and deposited on the Germanium plate.
The lipid-peptide sample was subjected to three different environmental conditions. Every
measurement is done at two polarizations of the infrared light with respect to the plate, which are
used to obtain a polarization independent spectrum as A=A|| + 1.44A┴. This spectrum is then
processed for second derivative determination and finally curve fitted to evaluate the secondary
structure determination. All the electric field components of the evanescent field need to be taken
into consideration (Marsh et al, 1999). The polarized spectra were used to calculate the dichroic
ratios and then the orientations of membrane-bound peptides.
Curve fitting is performed for the polarization independent spectra for each of the three cases of
dry, vaporized and buffer peptide sample. The curve fitting results for ATR-FTIR indicate that
the minimally hydrated samples of peptides in stacked lipid bilayers (absence of bulk water)
were mostly α-helical but adopted mostly β-sheet conformation in the presence of excess water.
Hence a larger peak around ~1627 cm-1 is seen in hydrated samples indicating the transformation
into more β-sheets.
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4.4.1 Bax KK

The wild type Bax peptide is first measured using dry lipid film on the Ge plate. Then the sample
hydrated with D2O vapors and finally flushed with D2O buffer to determine the change in the
secondary structure upon various environments. Increase in β-sheet structure was identified upon
exposure of the sample to bulk aqueous phase.

B

A

D
D
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Figure 13: ATR-FTIR spectra for Bax KK in 100% POPC (A-C) and 70% POPC and 30%
POPG (D-F) films deposited on the Ge plate in the absence hydration (A, D), exposed to D2O
vapor for 1 hr (B, E), and in the presence of bulk D2O-based buffer (C, F).

The dry sample has a greater percentage of helix in its secondary structure (A, D) compared to
when the sample is hydarated with D2O vapors for an hour (B, E). A greater peak is seen around
1624 implying an increase in the percentage of β sheets after vaporization. Finally the hydrated
sample (C, F) have very large β sheets implying more β sheet formation after D2O buffer
hydration.
As we can see that an iterative curve fitting between 1700 and 1600 cm-1 is a very important tool
in order to determine the area of amide I components. All the peaks generated during curve
fitting are based on secondary derivatives and hence closely correspond to various secondary
structures present in the peptide at that given environmental condition. Three different conditions
would yield three different ATR-FTIR spectra which were individually curve fitted. Sum of all
the peaks would give the entire amide I region and is called a „fitted peak‟. Finally the
percentage of one particular secondary structure present in the peptide can be calculated by
dividing its peak area by the total area of amide I region.
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4.4.2 Bax EE

The mutant Bax EE is also measured using dry lipid film on the Ge plate. Then the sample was
hydrated with D2O vapor and finally flushed with D2O buffer to determine the change in the
secondary structure upon various environmental changes. Again, excess water caused the peptide
to adopt a mostly -sheet conformation.

A

D

C

B

F

E

F

F

F

F

F

38

Figure 14: ATR-FTIR spectra for Bax EE in 100% POPC (A-C) and 70% POPC and 30% POPG
(D-F) films deposited on the Ge plate in the absence hydration (A, D), exposed to D2O vapor for
1 hr (B, E), and in the presence of bulk D2O-based buffer (C, F).

4.4.3 Bax LL

The mutant Bax LL is also measured using dry lipid film on the Ge plate. Then the sample was
hydrated with D2O and finally flushed with D2O buffer to determine the change in the secondary
structure upon various environmental changes.
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Figure 15: ATR-FTIR spectra for Bax LL in 100% POPC (A-C) and 70% POPC and 30% POPG
(D-F) films deposited on the Ge plate in the absence hydration (A, D), exposed to D2O vapor for
1 hr (B, E), and in the presence of bulk D2O-based buffer (C, F).
Note: Bax LL peptide was rich in β-sheet structure under all conditions.

Table 4: Fractions of alpha helix and beta sheet structures in peptides from ATR-FTIR data
along with the standard deviations.

Bax-KK

α

Bax-EE

Bax-LL

β

α

β

α

β

POPC

0.264+/0.001

0.198+/0.003

0.334+/0.067

0.325+/0.013

0.142 +/0.045

0.508+/0.271

POPC/POPG

0.306+/0.0217

0.361+/0.023

0.356+/0.002

0.454+/0.001

0.203+/0.001

0.571+/0.001
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4.5 Confirmation by Circular Dichroism

It has now been shown by the ATR-FTIR experiments that Bax peptides assume more -sheet
confirmation in the presence of bulk water. This idea was confirmed by CD experiments where
peptides were dissolved in aqueous buffer and readings were taken to study their secondary
structure. The β-sheets always give a minimum around 215 nm which was a characterizing
feature in all these spectra.

Figure 16: Structural analysis by CD confirming the mostly -sheet secondary structure of Bax
Peptides.
4.6 Depth of Membrane Insertion
Depth of membrane insertion was determined at both 20°C and 37°C by fluroscence quenching
of Trp by dibromo-phosphatidylcholines (Br2PCs). The effect of membrane charge was studied
by using pure 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) and 70% POPC + 30% 1palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) in membrane preparations with and without
Br2PCs brominated at 6,7-, or 9,10-, or 11,12 positions of the acyl chains.
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4.6.1. Fluorescence Spectra

The depth of membrane insertion was determined as described previously (Ray et al, 2007).

Figure 17: Fluorescence of Bax-KK measured using excitation at 290 nm, at 37oC. Pure POPC
(left) and 70% POPG + 30% POPG (right) are compared using same concentrations of
brominated lipids. (Blue- Pure Lipid, Orange- 6,7 Br2PC, Green- 9,10 Br2PC, Red- 11,12 Br2PC)
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Figure 18: Fluorescence of Bax-EE measured using excitation at 290 nm, at 37oC. Pure POPC (left) and
70% POPG + 30% POPG (right) are compared using same concentrations of brominated lipids. (BluePure Lipid, Orange- 6,7 Br2PC, Green- 9,10 Br2PC, Red- 11,12 Br2PC)

Figure 19: Fluorescence of Bax-LL measured using excitation at 290 nm, at 37oC. Pure POPC
(left) and 70% POPG + 30% POPG (right) are compared using same concentrations of
brominated lipids. (Blue- Pure Lipid, Orange- 6,7 Br2PC, Green- 9,10 Br2PC, Red- 11,12 Br2PC)
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4.6.2. Distribution Analysis
“Distribution analysis” of the experimental data was determined by the formulation as shown in
equation (10):

(10)

Where F0 is the fluorescence intensity without and F the intensity with quencher; S is the area
and σ the dispersion of the distribution curve; and h is the distance and hm is the most probable
distance from the membrane center (Ray et al, 2007).

The final concentration of Bax that was added to the suspension after preparation of the vesicles
was 30 μM. Lipid and protein concentrations ensured that most of the protein was bound to the
membranes. Spectra of blank buffer were measured as references and used for correction by
subtracting from the sample spectra. Samples were thermostated at each temperature for 5 min
before the spectra were recorded, with constant stirring by a magnetic stir bar in a 0.4 cm path
length quartz cuvette. The three values of ln (F0/F), which were obtained with three different
Br2PCs, were plotted as a function of the distance of bromines in Br2PCs from the membrane
center, i.e., 11.0, 8.3, and 6.5 Å for 6,7-, 9,10-, and 11,12-Br2PC respectively as shown in Fig 20.
Fitting of these data by Eq. (10) allowed determination of parameters S, σ, and hm.

44

Figure 20: “Distribution analysis” of all three peptides was performed using the equation which
results in individual fitted curves for pure POPC (A) and with 70% POPG + 30% POPG (B) lipid
compositions (Blue: Bax-KK, Green: Bax-LL, Red: Bax-EE).

Table 5: The “distribution analysis” parameters of various Bax mutants in two different lipid
compositions.

Bax-LL
S

Bax-KK

σ

hm

S

σ

Bax-EE
hm

S

σ

hm

POPC
(no POPG)

3.1

1.0

9.1

2.5

1.2

9.3

4.7

2.7

9.5

POPC+
30% POPG

9.0

3.5

5.3

12.0

3.1

2.7

2.1

1.49

8.9
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CHAPTER 5. DISCUSSION

Insertion of Bax into mitochindrial membrane is the hallmark of Apoptosis. The solution
structure of Bax has been solved (Torrecillas et al, 2008). However the exact mechanism of
its function is still unknown. For this reason elucidation of secondary structure and mode of
insertion becomes most important. With the calcein release experiments, it is established that
Bax C-terminal peptide is able to form pores in lipid membranes and cause vesicle content
release. Given the hydrodynamic radius of calcein of 0.64 nm, the pore has a diameter of at
least 1.3 nm or larger. Wild type Bax KK has the highest penetration in the lipid vesicles.
However for pure POPC membranes, Bax LL releases more calcein than vesicles made with
30% anionic lipids. Once we have established that different peptides have different rupture
powers for the lipid vesicles, we conducted structural studies to elucidate the molecular basis
for membrane pore formation by the peptides. Using brominated lipids the position of
tryptophan is determined and it is seen that for pure POPC membranes, Trp16 is around 9.3
Å from the membrane center and our results are consistent for all three peptides. However for
30% POPG, Trp16 was inserted much deeper; hm was seen to be around 2.7 and 5.3 Å for
wild type and Bax-LL peptides respectively but was at hm  9 Å for the Bax-EE peptide.
Thus, the wild type Bax peptide has the highest membrane insertion and the strongest
membrane perforation potency, which may play a role in pore formation in mitochondrial
membranes by Bax and cytochrome c release.
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Peptides applied to calcein-loaded vesicles resulted in gradual increase in calcein
fluorescence, apparently induced by membrane permeabilization by the peptides and calcein
release (Fig. 21). While the kinetics and the level of calcein release were dependant on
specific peptide, and its molar concentration as well as the lipid composition of vesicle
membranes. All traces of time-dependence of calcein fluorescence could be fitted with Ft =
Feq – a1exp(-k1t) – a2exp(-k2t), where Ft is calcein fluorescence intensity at time t, offset by
subtraction of the fluorescence before peptide addition, Feq is the extrapolated level of
fluorescence at t  , a1 and a2 are the fractions of the two kinetic components, and k1 and
k2 are the respective rate constants.
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Figure 21: Addition of the peptides to calcein-loaded vesicles resulted in gradual increase in
calcein fluorescence, apparently induced by membrane permeabilization by the peptides and
calcein release.
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Data of Fig. 22 indicate an initial linear time dependence of Feq/{[P]0(Feq – Ft)},characteristic of
a bimolecular reaction, followed by a second segment of linear dependence with a higher slope at
t  10 min (for POPC/POPG vesicles and 15 µM peptide the second segments starts earlier). The
data points corresponding to the second linear segment involve considerable noise because with
increasing time Ft approaches Feq and the values of Feq/{[P]0(Feq – Ft)}become progressively
unstable as the denominator decreases. Two linear segments of the graphs indicate that at least
two processes are involved in membrane pore formation. If membrane binding of the peptide is
relatively fast, as suggested by the 10-30 s time constant of the fast component of the doubleexponential curves for BaxC-KK, then both linear segments of the graphs of Fig. 22 should be
interpreted in terms of interactions between the peptide molecules within the membrane.

Figure 22: Spectra indicate an initial linear time dependence characteristic of a bimolecular
reaction, followed by a second segment of linear dependence after addition of BaxC-KK peptide
to the calcein-loaded vesicles.
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The final step in characterization of pore formation is evaluation of the oligomeric state of the
pore. This was achieved using a model of reversible aggregation that has been applied previously
to describe membrane pores formed by other peptides (Nir, Nieva. 2000, Nieva, 2003). The
mechanism of pore formation was analyzed using the slower double-exponential rate constants,
which are believed to reflect the kinetics of pore formation. Fig. 23 indicates that when values of
ka1 are used, which characterize the pore formation process at earlier times (5-10 min), the
experimental data for BaxC-KK agree with n  3-4 for POPC membranes (Fig. 23A) and n  2-3
for POPC/POPG membranes (Fig. 23B). When values of ka2 are used, which characterize further
progression of pore formation process, the data are consistent with n  8 for POPC membranes
(Fig. 23C) and n  5 for POPC/POPG membranes (Fig. 23D). Thus, the overall picture of
membrane pore formation by the wild-type BaxC-KK peptide is that the peptide molecules form
an initial nucleation complex involving 2-4 molecules and characterized with affinity constants
of (1.3-3.7)106 M-1 followed by a more efficient process (higher 2nd order rate constant) of the
assembly of the final pore structure involving up to 8 peptide molecules associated with affinity
constants of (0.5-1.4)107 M-1.
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Figure 23: Figure indicates that when values of ka1 are used, which characterize the pore
formation process at earlier times (5-10 min), the experimental data for BaxC-KK agree with n~
3-4 for POPC membranes (A) and n ~ 2-3 for POPC/POPG membranes (B). When values of ka2
are used, which characterize further progression of pore formation process, the data are
consistent with n~ 8 for POPC membranes (C) and n~5 for POPC/POPG membranes (D).

51

Depth of membrane insertion was performed to determine the varying rupturing power of
different petides in two different lipid compositions. These studies were performed to
complement our understanding of how these peptides create pores in the membranes and how
much they differ from each other in their pore forming abilities. Using brominated lipids, the
position of tryptophan is determined and it is seen that for pure POPC membranes, Trp16 sits at a
farther distance from the membrane center, both above and below while it got inserted much
deeper when the lipid was incorporated with 30% POPG. Additionally with 30% POPG
composition, the insertion ability differs with each mutant and Bax KK was seen to have the
highest penetration into the membrane while Bax LL showed the least. This is in contrast with
the pure POPC membranes where all three mutants share almost similar insertion. From all these
studies, we conclude that wild type Bax has the highest penetration in the lipid membrane and
would expedite the release of cytochrome c.
We have seen that Bax peptide and its mutants penetrate into the lipid membrane and have a
certain depth of insertion; we are interested in determining the secondary structures for the
peptide in various environments. As the peptide is exposed more to the buffer, the amount of β
sheets increase while α helices go down. In the dry sample, more α-helices are seen and in the
hydrated sample, amount of sheets increases dramatically. This indicates that the mode of
action of Bax C-terminal peptide may involve a β barrel-like structure. In conclusion, our studies
have identified that Bax C-terminal peptide itself has the potency of forming relatively large
pores in lipid membranes. The wild type peptide with two lysine residues is more potent than the
charge-reversal or charge neutralization mutant peptides in pore formation. CD and FTIR studies
indicate that under physiologically relevant conditions, the peptide‟s secondary structure

52

contains significant fractions of -sheet. Finally, fluorescence quenching experiments identify a
pattern of membrane insertion of the peptides that is consistent with a -barrel-type structure of
membrane pores. It should be expected that the behavior of the isolated peptides would be
different than when it is attached to the protein. However, these findings are encouraging in
terms of developing cytotoxic peptide-based molecular tools for cell membrane perforation and
killing of unwanted cells such as bacteria, fungi, or cancer cells.
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